Human Molecular Genetics Advance Access originally published online on February 22, 2007
Human Molecular Genetics 2007 16(6):609-617; doi:10.1093/hmg/ddm001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure
1 Glaucoma Research, Alcon Research, Ltd., 6201 South Freeway, Fort Worth, TX 76134, USA, 2 Howard Hughes Medical Institute, University of Iowa, Iowa City, IA 52242, USA, 3 Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA and 4 Department of Ophthalmology, University of Iowa, Iowa City, IA 52242, USA
* To whom correspondence should be addressed. Tel: +1 8176152312; Fax: +1 8175687553; Email: allan.shepard{at}alconlabs.com
Received January 3, 2007; Accepted January 9, 2007
Glaucoma is a leading cause of worldwide irreversible visual impairment and blindness and is a clinically and genetically heterogenous group of optic neuropathies. Specific mutations in the myocilin (MYOC) gene cause primary open angle glaucoma (POAG) with varying age-of-onset and degree of severity. We show a mutation-dependent, gain-of-function association between human myocilin and the peroxisomal targeting signal type 1 receptor (PTS1R). There was correlation between the glaucoma phenotype and the specific MYOC mutations, with the more severe early-onset POAG mutations having a higher degree of association with PTS1R. Expression of human myocilin glaucomatous mutations in mouse eyes causes elevated intraocular pressure, which is a major phenotype of MYOC glaucoma. This is the first demonstration of a disease resulting from mutation-induced exposure of a cryptic signaling site that causes mislocalization of mutant protein to peroxisomes and the first disease-gene-based animal model of human POAG.
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. H. Kwon, J. H. Fingert, M. H. Kuehn, and W. L.M. Alward Primary Open-Angle Glaucoma N. Engl. J. Med., March 12, 2009; 360(11): 1113 - 1124. [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Hoffman, K. M. Perkumas, L. M. Highstrom, and W. D. Stamer Regulation of Myocilin-Associated Exosome Release from Human Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1313 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Skarie and B. A. Link The Primary open-angle glaucoma gene WDR36 functions in ribosomal RNA processing and interacts with the p53 stress-response pathway Hum. Mol. Genet., August 15, 2008; 17(16): 2474 - 2485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhou, O. Grinchuk, and S. I. Tomarev Transgenic Mice Expressing the Tyr437His Mutant of Human Myocilin Protein Develop Glaucoma Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1932 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-H. Wang, L. G. McNatt, I.-H. Pang, P. E. Hellberg, J. H. Fingert, M. D. McCartney, and A. F. Clark Increased Expression of Serum Amyloid A in Glaucoma and Its Effect on Intraocular Pressure Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1916 - 1923. [Abstract] [Full Text] [PDF]
|
|